Quick answers
- What is Combogesic IV?
- Combogesic IV is a brand name of Acetaminophen and ibuprofen, a prescription medicine. The FDA NDC Directory lists 1 Combogesic IV product in 1 strength and form.
- Who makes Combogesic IV?
- Hikma holds the FDA application for Combogesic IV (NDA215320, approved October 17, 2023).
- Is there a generic or store brand of Combogesic IV?
- Other products of Acetaminophen and ibuprofen are listed with the FDA, but none in exactly the same strength and form as a Combogesic IV product.
- Has Combogesic IV been recalled?
- No recall linked to Combogesic IV products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Combogesic IV is
Each Combogesic IV product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Acetaminophen and ibuprofen · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| acetaminophen 1000 mg/100 mL · ibuprofen 300 mg/100 mL injection (intravenous) | Combogesic IV | None listed | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Acetaminophen and ibuprofen →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA215320 | Hikma | October 17, 2023 | 1 |
Companies that list Combogesic IV
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Combogesic IV products.
- Hikma Pharmaceuticals USA Inc.1 product
Recalls
No recall linked to Combogesic IV products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.